Daiichi Sankyo Company, Limited (4568.T)
JPY 3216.0
(1.32%)
JPY 3216.0
(1.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1763.11 Billion JPY | 65.86% |
| 2022 | 1063.03 Billion JPY | 22.11% |
| 2021 | 870.53 Billion JPY | 7.06% |
| 2020 | 813.12 Billion JPY | 1.72% |
| 2019 | 799.34 Billion JPY | -4.65% |
| 2018 | 838.34 Billion JPY | 9.63% |
| 2017 | 764.71 Billion JPY | 2.85% |
| 2016 | 743.55 Billion JPY | 11.48% |
| 2015 | 667 Billion JPY | -1.22% |
| 2014 | 675.24 Billion JPY | -20.23% |
| 2013 | 846.51 Billion JPY | 16.23% |
| 2012 | 728.32 Billion JPY | 6.21% |
| 2011 | 685.73 Billion JPY | 15.73% |
| 2010 | 592.53 Billion JPY | -1.24% |
| 2009 | 600 Billion JPY | -0.99% |
| 2008 | 605.98 Billion JPY | 149.38% |
| 2007 | 242.99 Billion JPY | -33.37% |
| 2006 | 364.68 Billion JPY | 5.1% |
| 2005 | 346.98 Billion JPY | 38.68% |
| 2004 | 250.2 Billion JPY | 6.11% |
| 2003 | 235.8 Billion JPY | -5.19% |
| 2002 | 248.7 Billion JPY | 0.0% |
| 2001 | - JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| 1999 | - JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1674.32 Billion JPY | -2.44% |
| 2024 Q1 | 1716.28 Billion JPY | -2.66% |
| 2023 Q2 | 1055.09 Billion JPY | -2.86% |
| 2023 Q3 | 1681.83 Billion JPY | 59.4% |
| 2023 FY | 1763.11 Billion JPY | 65.86% |
| 2023 Q4 | 1763.11 Billion JPY | 4.83% |
| 2023 Q1 | 1086.2 Billion JPY | 2.18% |
| 2022 Q4 | 1063.03 Billion JPY | 8.06% |
| 2022 FY | 1063.03 Billion JPY | 22.11% |
| 2022 Q2 | 960.62 Billion JPY | 7.42% |
| 2022 Q1 | 894.29 Billion JPY | 2.73% |
| 2022 Q3 | 983.71 Billion JPY | 2.4% |
| 2021 Q4 | 870.53 Billion JPY | 4.6% |
| 2021 FY | 870.53 Billion JPY | 7.06% |
| 2021 Q1 | 782.37 Billion JPY | -3.78% |
| 2021 Q2 | 798.5 Billion JPY | 2.06% |
| 2021 Q3 | 832.25 Billion JPY | 4.23% |
| 2020 Q1 | 747.07 Billion JPY | -6.54% |
| 2020 Q3 | 759.87 Billion JPY | 1.85% |
| 2020 Q4 | 813.12 Billion JPY | 7.01% |
| 2020 Q2 | 746.03 Billion JPY | -0.14% |
| 2020 FY | 813.12 Billion JPY | 1.72% |
| 2019 Q3 | 759.46 Billion JPY | -1.42% |
| 2019 Q1 | 806.05 Billion JPY | -3.85% |
| 2019 FY | 799.34 Billion JPY | -4.65% |
| 2019 Q4 | 799.34 Billion JPY | 5.25% |
| 2019 Q2 | 770.43 Billion JPY | -4.42% |
| 2018 Q1 | 679.81 Billion JPY | -11.1% |
| 2018 Q2 | 659.94 Billion JPY | -2.92% |
| 2018 Q3 | 658.57 Billion JPY | -0.21% |
| 2018 Q4 | 838.34 Billion JPY | 27.3% |
| 2018 FY | 838.34 Billion JPY | 9.63% |
| 2017 Q2 | 746.29 Billion JPY | -1.05% |
| 2017 Q3 | 752.83 Billion JPY | 0.88% |
| 2017 Q4 | 764.71 Billion JPY | 1.58% |
| 2017 FY | 764.71 Billion JPY | 2.85% |
| 2017 Q1 | 754.24 Billion JPY | 1.44% |
| 2016 FY | 743.55 Billion JPY | 11.48% |
| 2016 Q3 | 760.51 Billion JPY | 0.03% |
| 2016 Q2 | 760.32 Billion JPY | 15.97% |
| 2016 Q1 | 655.64 Billion JPY | -1.7% |
| 2016 Q4 | 743.55 Billion JPY | -2.23% |
| 2015 Q3 | 652.97 Billion JPY | 3.54% |
| 2015 Q2 | 630.63 Billion JPY | -2.34% |
| 2015 Q1 | 645.77 Billion JPY | -4.36% |
| 2015 FY | 667 Billion JPY | -1.22% |
| 2015 Q4 | 667 Billion JPY | 2.15% |
| 2014 Q1 | 755.2 Billion JPY | -10.79% |
| 2014 Q4 | 675.24 Billion JPY | -18.6% |
| 2014 Q3 | 829.49 Billion JPY | 6.83% |
| 2014 Q2 | 776.42 Billion JPY | 2.81% |
| 2014 FY | 675.24 Billion JPY | -20.23% |
| 2013 FY | 846.51 Billion JPY | 16.23% |
| 2013 Q4 | 846.51 Billion JPY | 2.57% |
| 2013 Q3 | 825.3 Billion JPY | 0.8% |
| 2013 Q2 | 818.75 Billion JPY | 10.97% |
| 2013 Q1 | 737.84 Billion JPY | 1.31% |
| 2012 Q3 | 671.55 Billion JPY | -0.18% |
| 2012 Q4 | 728.32 Billion JPY | 8.45% |
| 2012 FY | 728.32 Billion JPY | 6.21% |
| 2012 Q1 | 680.7 Billion JPY | -0.73% |
| 2012 Q2 | 672.78 Billion JPY | -1.16% |
| 2011 Q1 | 589.51 Billion JPY | -0.51% |
| 2011 Q4 | 685.73 Billion JPY | 10.34% |
| 2011 Q3 | 621.47 Billion JPY | 7.56% |
| 2011 FY | 685.73 Billion JPY | 15.73% |
| 2011 Q2 | 577.8 Billion JPY | -1.99% |
| 2010 Q2 | 572.87 Billion JPY | -0.88% |
| 2010 Q3 | 578.69 Billion JPY | 1.02% |
| 2010 Q4 | 592.53 Billion JPY | 2.39% |
| 2010 FY | 592.53 Billion JPY | -1.24% |
| 2010 Q1 | 577.98 Billion JPY | -3.67% |
| 2009 FY | 600 Billion JPY | -0.99% |
| 2009 Q4 | 600 Billion JPY | 7.82% |
| 2009 Q3 | 556.49 Billion JPY | -4.07% |
| 2009 Q2 | 580.09 Billion JPY | 0.0% |
| 2008 Q4 | 605.98 Billion JPY | 0.0% |
| 2008 FY | 605.98 Billion JPY | 149.38% |
| 2007 FY | 242.99 Billion JPY | -33.37% |
| 2006 FY | 364.68 Billion JPY | 5.1% |
| 2005 FY | 346.98 Billion JPY | 38.68% |
| 2004 FY | 250.2 Billion JPY | 6.11% |
| 2003 FY | 235.8 Billion JPY | -5.19% |
| 2002 FY | 248.7 Billion JPY | 0.0% |
| 2001 FY | - JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| 1999 FY | - JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 189.52 Billion JPY | -830.291% |
| Astellas Pharma Inc. | 1973.61 Billion JPY | 10.666% |
| Chugai Pharmaceutical Co., Ltd. | 306.96 Billion JPY | -474.368% |
| Ono Pharmaceutical Co., Ltd. | 115.06 Billion JPY | -1432.304% |
| Santen Pharmaceutical Co., Ltd. | 130.33 Billion JPY | -1252.808% |
| JCR Pharmaceuticals Co., Ltd. | 45.74 Billion JPY | -3753.888% |
| Otsuka Holdings Co., Ltd. | 924.92 Billion JPY | -90.623% |
| Perseus Proteomics Inc. | 295.46 Million JPY | -596625.5% |